Integer Holdings Corporation (ITGR)
USD 118.04
(2.25%)
USD 118.04
(2.25%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 239.71 Million USD | 14.83% |
| 2022 | 208.76 Million USD | 34.08% |
| 2021 | 155.69 Million USD | 4.27% |
| 2020 | 149.32 Million USD | -10.72% |
| 2019 | 167.25 Million USD | -12.01% |
| 2018 | 190.07 Million USD | -16.46% |
| 2017 | 227.53 Million USD | 1.06% |
| 2016 | 225.15 Million USD | -10.71% |
| 2015 | 252.16 Million USD | 95.11% |
| 2014 | 129.24 Million USD | 9.2% |
| 2013 | 118.35 Million USD | 11.02% |
| 2012 | 106.61 Million USD | -3.0% |
| 2011 | 109.91 Million USD | 8.35% |
| 2010 | 101.44 Million USD | -4.85% |
| 2009 | 106.6 Million USD | -5.07% |
| 2008 | 112.3 Million USD | 56.23% |
| 2007 | 71.88 Million USD | 24.65% |
| 2006 | 57.66 Million USD | 27.63% |
| 2005 | 45.18 Million USD | 32.79% |
| 2004 | 34.02 Million USD | 18.98% |
| 2003 | 28.59 Million USD | -18.08% |
| 2002 | 34.9 Million USD | 20.26% |
| 2001 | 29.02 Million USD | 112.75% |
| 2000 | 13.64 Million USD | 0.44% |
| 1999 | 13.58 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 272.33 Million USD | 3.6% |
| 2024 Q1 | 262.86 Million USD | 9.66% |
| 2024 Q3 | 265.41 Million USD | -2.54% |
| 2023 Q3 | 232.15 Million USD | 1.41% |
| 2023 Q1 | 225.28 Million USD | 7.91% |
| 2023 FY | 239.71 Million USD | 14.83% |
| 2023 Q2 | 228.93 Million USD | 1.62% |
| 2023 Q4 | 239.71 Million USD | 3.26% |
| 2022 Q4 | 208.76 Million USD | -0.8% |
| 2022 Q1 | 173.31 Million USD | 11.31% |
| 2022 Q2 | 194.45 Million USD | 12.2% |
| 2022 Q3 | 210.45 Million USD | 8.23% |
| 2022 FY | 208.76 Million USD | 34.08% |
| 2021 Q3 | 149.23 Million USD | 0.95% |
| 2021 Q2 | 147.83 Million USD | -3.89% |
| 2021 FY | 155.69 Million USD | 4.27% |
| 2021 Q1 | 153.81 Million USD | 3.01% |
| 2021 Q4 | 155.69 Million USD | 4.33% |
| 2020 Q4 | 149.32 Million USD | -4.8% |
| 2020 Q1 | 170.29 Million USD | 1.82% |
| 2020 Q2 | 172.45 Million USD | 1.27% |
| 2020 Q3 | 156.85 Million USD | -9.05% |
| 2020 FY | 149.32 Million USD | -10.72% |
| 2019 FY | 167.25 Million USD | -12.01% |
| 2019 Q4 | 167.25 Million USD | -15.52% |
| 2019 Q1 | 181.2 Million USD | -4.67% |
| 2019 Q3 | 197.97 Million USD | 5.78% |
| 2019 Q2 | 187.15 Million USD | 3.29% |
| 2018 Q3 | 193.63 Million USD | -0.69% |
| 2018 FY | 190.07 Million USD | -16.46% |
| 2018 Q4 | 190.07 Million USD | -1.84% |
| 2018 Q2 | 194.97 Million USD | -18.59% |
| 2018 Q1 | 239.49 Million USD | 5.25% |
| 2017 Q4 | 227.53 Million USD | -7.87% |
| 2017 Q3 | 246.97 Million USD | 4.84% |
| 2017 Q2 | 235.56 Million USD | 1.85% |
| 2017 FY | 227.53 Million USD | 1.06% |
| 2017 Q1 | 231.29 Million USD | 2.73% |
| 2016 FY | 225.15 Million USD | -10.71% |
| 2016 Q2 | 276.27 Million USD | 3.33% |
| 2016 Q1 | 267.38 Million USD | 6.03% |
| 2016 Q4 | 225.15 Million USD | -14.14% |
| 2016 Q3 | 262.23 Million USD | -5.08% |
| 2015 Q1 | 137.98 Million USD | 6.77% |
| 2015 Q2 | 140.09 Million USD | 1.52% |
| 2015 FY | 252.16 Million USD | 95.11% |
| 2015 Q3 | 164.23 Million USD | 17.23% |
| 2015 Q4 | 252.16 Million USD | 53.54% |
| 2014 FY | 129.24 Million USD | 9.2% |
| 2014 Q3 | 128.72 Million USD | 6.73% |
| 2014 Q4 | 129.24 Million USD | 0.4% |
| 2014 Q1 | 118.08 Million USD | -0.23% |
| 2014 Q2 | 120.61 Million USD | 2.14% |
| 2013 Q2 | 122.16 Million USD | 3.37% |
| 2013 Q1 | 118.17 Million USD | 10.85% |
| 2013 Q3 | 122.82 Million USD | 0.54% |
| 2013 Q4 | 118.35 Million USD | -3.64% |
| 2013 FY | 118.35 Million USD | 11.02% |
| 2012 Q3 | 111.16 Million USD | -2.19% |
| 2012 Q1 | 112.45 Million USD | 2.31% |
| 2012 FY | 106.61 Million USD | -3.0% |
| 2012 Q4 | 106.61 Million USD | -4.09% |
| 2012 Q2 | 113.65 Million USD | 1.07% |
| 2011 FY | 109.91 Million USD | 8.35% |
| 2011 Q4 | 109.91 Million USD | -4.67% |
| 2011 Q3 | 115.29 Million USD | 4.75% |
| 2011 Q2 | 110.06 Million USD | 7.13% |
| 2011 Q1 | 102.73 Million USD | 1.28% |
| 2010 FY | 101.44 Million USD | -4.85% |
| 2010 Q1 | 105.92 Million USD | -0.64% |
| 2010 Q4 | 101.44 Million USD | -3.18% |
| 2010 Q3 | 104.77 Million USD | 3.6% |
| 2010 Q2 | 101.13 Million USD | -4.52% |
| 2009 FY | 106.6 Million USD | -5.07% |
| 2009 Q2 | 116.4 Million USD | -1.21% |
| 2009 Q3 | 115.76 Million USD | -0.55% |
| 2009 Q4 | 106.6 Million USD | -7.91% |
| 2009 Q1 | 117.82 Million USD | 4.92% |
| 2008 Q2 | 93.63 Million USD | -0.34% |
| 2008 Q1 | 93.96 Million USD | 30.71% |
| 2008 FY | 112.3 Million USD | 56.23% |
| 2008 Q4 | 112.3 Million USD | 13.63% |
| 2008 Q3 | 98.83 Million USD | 5.55% |
| 2007 Q1 | 54.48 Million USD | -5.52% |
| 2007 FY | 71.88 Million USD | 24.65% |
| 2007 Q4 | 71.88 Million USD | 4.84% |
| 2007 Q3 | 68.56 Million USD | 7.21% |
| 2007 Q2 | 63.95 Million USD | 17.38% |
| 2006 Q1 | 48.2 Million USD | 6.67% |
| 2006 FY | 57.66 Million USD | 27.63% |
| 2006 Q3 | 54.65 Million USD | 5.9% |
| 2006 Q4 | 57.66 Million USD | 5.51% |
| 2006 Q2 | 51.61 Million USD | 7.08% |
| 2005 FY | 45.18 Million USD | 32.79% |
| 2005 Q1 | 32.27 Million USD | -5.14% |
| 2005 Q2 | 33.67 Million USD | 4.32% |
| 2005 Q3 | 36.15 Million USD | 7.38% |
| 2005 Q4 | 45.18 Million USD | 24.97% |
| 2004 FY | 34.02 Million USD | 18.98% |
| 2004 Q4 | 34.02 Million USD | 2.04% |
| 2004 Q3 | 33.34 Million USD | 1.09% |
| 2004 Q2 | 32.98 Million USD | 5.13% |
| 2004 Q1 | 31.37 Million USD | 9.72% |
| 2003 Q1 | 32.71 Million USD | -6.28% |
| 2003 Q3 | 30.73 Million USD | -5.85% |
| 2003 Q2 | 32.64 Million USD | -0.21% |
| 2003 Q4 | 28.59 Million USD | -6.97% |
| 2003 FY | 28.59 Million USD | -18.08% |
| 2002 FY | 34.9 Million USD | 20.26% |
| 2002 Q3 | 32.3 Million USD | 4.93% |
| 2002 Q1 | 31.6 Million USD | 8.87% |
| 2002 Q2 | 30.78 Million USD | -2.57% |
| 2002 Q4 | 34.9 Million USD | 8.05% |
| 2001 FY | 29.02 Million USD | 112.75% |
| 2001 Q1 | 15.94 Million USD | 16.9% |
| 2001 Q2 | 23.15 Million USD | 45.17% |
| 2001 Q3 | 25.74 Million USD | 11.18% |
| 2001 Q4 | 29.02 Million USD | 12.77% |
| 2000 FY | 13.64 Million USD | 0.44% |
| 2000 Q4 | 13.64 Million USD | -5.05% |
| 2000 Q3 | 14.36 Million USD | 0.0% |
| 1999 FY | 13.58 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Abbott Laboratories | 6.57 Billion USD | 96.351% |
| Allurion Technologies Inc. | 6.17 Million USD | -3784.557% |
| Artivion, Inc. | 81.97 Million USD | -192.422% |
| Avanos Medical, Inc. | 163.2 Million USD | -46.885% |
| Butterfly Network, Inc. | 75.83 Million USD | -216.094% |
| Butterfly Network, Inc. | 75.83 Million USD | -216.094% |
| Bio-Rad Laboratories, Inc. | 780.51 Million USD | 69.288% |
| Boston Scientific Corporation | 2.48 Billion USD | 90.35% |
| CONMED Corporation | 318.32 Million USD | 24.694% |
| Edwards Lifesciences Corporation | 1.16 Billion USD | 79.48% |
| Paragon 28, Inc. | 98.06 Million USD | -144.454% |
| Glaukos Corporation | 41.98 Million USD | -470.943% |
| Globus Medical, Inc. | 848.13 Million USD | 71.736% |
| Inspire Medical Systems, Inc. | 33.88 Million USD | -607.44% |
| Medtronic plc | 5.21 Billion USD | 95.405% |
| Myomo, Inc. | 1.8 Million USD | -13191.659% |
| Nevro Corp. | 118.67 Million USD | -101.992% |
| Owlet, Inc. | 6.49 Million USD | -3591.914% |
| Penumbra, Inc. | 388.02 Million USD | 38.221% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 89.991% |
| Sonendo, Inc. | 11.07 Million USD | -2064.674% |
| STERIS plc | 674.53 Million USD | 64.462% |
| Stryker Corporation | 4.84 Billion USD | 95.05% |
| Vapotherm, Inc. | 22.96 Million USD | -943.696% |
| Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 89.95% |